Chandra Bhagat Pharma Limited (BOM:542934)

India · Delayed Price · Currency is INR

44.59

-2.34 (-4.99%)

At close: Oct 6, 2026

Market Cap	336.43M +3.7%
Revenue (ttm)	1.17B +28.5%
Net Income	30.46M +255.1%
EPS	4.04 +255.1%
Shares Out	7.55M
PE Ratio	11.04
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Open	44.59
Previous Close	46.93
Day's Range	44.59 - 44.59
52-Week Range	29.70 - 52.99
Beta	0.38
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Chandra Bhagat Pharma

Chandra Bhagat Pharma Limited, a pharmaceutical company, markets pharmaceutical critical care and health care products in India and internationally. The company offers pharmaceutical formulations, including intravenous and intramuscular injections, oral solids, tablets, capsules, liquid orals, syrup suspensions, injectable liquids, powders, lyophilized ampoules, vials, prefilled syringes, and small and large volume parenteral for various therapeutic categories, such as anti-cancer, anti-infective, antibiotics, anesthesia, hormones, orthopedic, ... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries

Founded 1944

Employees 45

Stock Exchange Bombay Stock Exchange

Ticker Symbol 542934

Full Company Profile

Financial Performance

In fiscal year 2026, Chandra Bhagat Pharma's revenue was 1.17 billion, an increase of 28.53% compared to the previous year's 908.56 million. Earnings were 30.46 million, an increase of 255.11%.

Financial Statements